These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26191247)

  • 1. TMPRSS3 is a novel poor prognostic factor for breast cancer.
    Rui X; Li Y; Jin F; Li F
    Int J Clin Exp Pathol; 2015; 8(5):5435-42. PubMed ID: 26191247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival.
    Pelkonen M; Luostari K; Tengström M; Ahonen H; Berdel B; Kataja V; Soini Y; Kosma VM; Mannermaa A
    BMC Cancer; 2015 May; 15():431. PubMed ID: 26014348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of TMPRSS3 and TNFRSF11B correlates with tumorigenesis and poor prognosis in patients with breast cancer.
    Luo P; Lu G; Fan LL; Zhong X; Yang H; Xie R; Lv Z; Lv QZ; Fu D; Yang LX; Ma Y
    Oncol Rep; 2017 Apr; 37(4):2057-2062. PubMed ID: 28260080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MAC30 protein is related to survival and clinicopathological variables in breast cancer.
    Xiao M; Li H; Yang S; Huang Y; Jia S; Wang H; Wang J; Li Z
    J Surg Oncol; 2013 Apr; 107(5):456-62. PubMed ID: 22996179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of the transmembrane protease serine 3 mRNA level in radioresistant colorectal cancer tissues.
    Wen JY; Fang YY; Chen G; He RQ; Huang HQ; Wang RS; Zeng DT; Huang WJ; Qin XG
    Biomark Med; 2022 Jun; 16(9):693-715. PubMed ID: 35543030
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.
    Zheng A; Zhang L; Song X; Wang Y; Wei M; Jin F
    BMC Cancer; 2019 May; 19(1):451. PubMed ID: 31088422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
    Zhang XF; Liu T; Li Y; Li S
    Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBXIP expression predicts patient prognosis in breast cancer.
    Cheng D; Liang B; Li Y
    Med Oncol; 2014 Oct; 31(10):210. PubMed ID: 25178941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of long non-coding RNA linc-ITGB1 in breast cancer and its influence on prognosis and survival.
    Li WX; Sha RL; Bao JQ; Luan W; Su RL; Sun SR
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3397-3401. PubMed ID: 28829502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear PARP1 expression and its prognostic significance in breast cancer patients.
    Mazzotta A; Partipilo G; De Summa S; Giotta F; Simone G; Mangia A
    Tumour Biol; 2016 May; 37(5):6143-53. PubMed ID: 26614429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
    Michaelidou K; Ardavanis A; Scorilas A
    Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of TMPRSS4 in prostate cancer.
    Shi G; Yang X; Dai B; Zhang H; Shen Y; Zhu Y; Zhu Y; Xiao W; Ma C; Wen L; Qin X; Cao D; Ye D
    Int J Clin Exp Pathol; 2014; 7(11):8053-8. PubMed ID: 25550850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.
    Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S
    Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
    Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
    J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer.
    Li XM; Liu WL; Chen X; Wang YW; Shi DB; Zhang H; Ma RR; Liu HT; Guo XY; Hou F; Li M; Gao P
    Int J Mol Med; 2017 Apr; 39(4):927-935. PubMed ID: 28259959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
    Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
    Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
    Wang S; Li H; Wang J; Wang D; Yao A; Li Q
    Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMPRSS3 modulates ovarian cancer cell proliferation, invasion and metastasis.
    Zhang D; Qiu S; Wang Q; Zheng J
    Oncol Rep; 2016 Jan; 35(1):81-8. PubMed ID: 26531004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer.
    Jin Q; Liu G; Wang B; Li S; Ni K; Wang C; Ren J; Zhang S; Dai Y
    J Clin Pathol; 2020 Dec; 73(12):803-812. PubMed ID: 32404475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of ultrasonographic features with NGX6 expression and prognosis in invasive ductal breast carcinoma.
    Xiao J; Zhou Y; Zhu W
    Int J Clin Exp Pathol; 2015; 8(6):6458-65. PubMed ID: 26261522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.